For: | Wieder HA, Lassmann M, Allen-Auerbach MS, Czernin J, Herrmann K. Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters. World J Radiol 2014; 6(7): 480-485 [PMID: 25071888 DOI: 10.4329/wjr.v6.i7.480] |
---|---|
URL: | https://www.wjgnet.com/1949-8470/full/v6/i7/480.htm |
Number | Citing Articles |
1 |
|
2 |
M. Basely, D. Métivier, O. Aupée, S. Le Moulec, C. Hélissey, F.-R. Ferrand, A. Frison-Roche, M. Tazdaït, E. Gontier. Radiothérapie interne par dichlorure de radium223 : résultats préliminaires. Médecine Nucléaire 2015; 39(5): 471 doi: 10.1016/j.mednuc.2015.08.003
|
3 |
Paul E. Wallner, Don C. Yoo, Jeremie Calais, Freddy E. Escorcia, Carina Mari Aparici, Jeff Michalski, Michael Morris, Zachary S. Morris, Daniel Pryma, Bryan M. Rabatic, Navesh Sharma, Neha Vapiwala, Munir V. Ghesani, Rathan M. Subramaniam, William Small, Naomi R. Schechter. ACR–ACNM–ARS–ASTRO–SNMMI Practice Parameter for the Performance of Therapy With Radiopharmaceuticals. American Journal of Clinical Oncology 2024; 47(4): 169 doi: 10.1097/COC.0000000000001072
|
4 |
Hümeyra BATTAL, Suna ERDOĞAN. The Role of Radiopharmaceuticals in the Bone Metastases Therapy. Fabad Journal of Pharmaceutical Sciences 2023; doi: 10.55262/fabadeczacilik.1191048
|
5 |
Arlindo R. Ferreira, André Abrunhosa-Branquinho, Marília Jorge, Luís Costa, Inês Vaz-Luís. International Manual of Oncology Practice. 2015; : 867 doi: 10.1007/978-3-319-21683-6_40
|
6 |
Patricia E. Edem, Jesper Fonslet, Andreas Kjær, Matthias Herth, Gregory Severin. In Vivo Radionuclide Generators for Diagnostics and Therapy. Bioinorganic Chemistry and Applications 2016; 2016: 1 doi: 10.1155/2016/6148357
|
7 |
Vincenzo Serretta, Maria Rosaria Valerio, Renato Costa, Vincenzo Tripoli, Alessandra Murabito, Alessandro Princiotta, Cristina Scalici Gesolfo, Nicolò Borsellino, Francesco Verderame, Vittorio Gebbia, Maria Licari, Chiara Sanfilippo. Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?. Urologic Oncology: Seminars and Original Investigations 2019; 37(12): 964 doi: 10.1016/j.urolonc.2019.08.009
|
8 |
Benedetta Pagano, Sergio Baldari. Clinical Applications of Nuclear Medicine Targeted Therapy. 2018; : 345 doi: 10.1007/978-3-319-63067-0_26
|
9 |
Vinod Patel, Megan Burns, Sheelen Patel, Sanford Grossman, Rana Wali, Isabel Sassoon, Elias Pintus, Marianne Henien. The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 3: prostate cancer. British Dental Journal 2022; doi: 10.1038/s41415-022-3928-0
|
10 |
E. Johanna L. Stéen, Patricia E. Edem, Kamilla Nørregaard, Jesper T. Jørgensen, Vladimir Shalgunov, Andreas Kjaer, Matthias M. Herth. Pretargeting in nuclear imaging and radionuclide therapy: Improving efficacy of theranostics and nanomedicines. Biomaterials 2018; 179: 209 doi: 10.1016/j.biomaterials.2018.06.021
|
11 |
|
12 |
Rebecca King, Nikki Tanna, Vinod Patel. Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab—a review. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2019; 127(4): 289 doi: 10.1016/j.oooo.2018.11.012
|
13 |
Helena Luna Pais, Irina Alho, Inês Vendrell, André Mansinho, Luís Costa. Radionuclides in oncology clinical practice – review of the literature. Dalton Transactions 2017; 46(42): 14475 doi: 10.1039/C7DT01929G
|
14 |
Luigia Florimonte, Luca Dellavedova, Lorenzo Stefano Maffioli. Radium-223 dichloride in clinical practice: a review. European Journal of Nuclear Medicine and Molecular Imaging 2016; 43(10): 1896 doi: 10.1007/s00259-016-3386-5
|
15 |
Roger von Moos, Luis Costa, Carla Ida Ripamonti, Daniela Niepel, Daniele Santini. Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain. European Journal of Cancer 2017; 71: 80 doi: 10.1016/j.ejca.2016.10.021
|